id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0152-0009,FDA,FDA-2011-E-0152,"U.S. Patent and Trademark Office to Dainippono Sumitomo Pharma Co., Ltd. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP)  - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T15:05:23Z,,0,0,09000064812bdd53
FDA-2011-E-0152-0008,FDA,FDA-2011-E-0152,Notice of Final Determination - Letter,Other,Letter(s),2013-03-15T04:00:00Z,2013,3,2013-03-15T04:00:00Z,,2013-03-15T13:44:39Z,,0,0,090000648122cf55